RESI 2023 (In person and Virtual)

位置: Boston

日期:

活動詳細資訊:

The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners across the lifescience and healthcare industry.

Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme. Our Novotech clinical team have almost 20 years’ experience working on 500+ early phase studies, making us an exceptionally experienced local provider within the Australian & New Zealand market and a partner of choice for many international biotech companies.   Dates for RESI : June 5 in person | June 6-7 virtual

預約會面

與會者

Novotech

John Moller

Novotech
Chief Executive Officer
Novotech

Barry Murphy

Novotech
Chief Commercial Officer
Novotech China

Andy Liu

Novotech China
Head of China

Plus team members from our Novotech China, Novotech DDC and US BD teams